The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V

[1]  S. Morini,et al.  The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  Alan M. Kwong,et al.  Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers , 2015, Nature Genetics.

[3]  Xi-Long Zheng,et al.  Lipoprotein lipase: from gene to atherosclerosis. , 2014, Atherosclerosis.

[4]  B. Melegh,et al.  Mutations of the apolipoprotein A5 gene with inherited hypertriglyceridaemia: review of the current literature. , 2012, Current medicinal chemistry.

[5]  M. Guardiola,et al.  APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  G. Olivecrona,et al.  Apolipoprotein A-V; a potent triglyceride reducer. , 2011, Atherosclerosis.

[7]  S. Kathiresan,et al.  Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.

[8]  S. Mariotti,et al.  Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes , 2009, Diabetes/metabolism research and reviews.

[9]  R. D'Agostino,et al.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.

[10]  P. Talmud,et al.  Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia Published, JLR Papers in Press, July 21, 2006. , 2006, Journal of Lipid Research.

[11]  P. Talmud,et al.  Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study Published, JLR Papers in Press, June 12, 2006. , 2006, Journal of Lipid Research.

[12]  P. Talmud,et al.  The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II , 2006, Diabetologia.

[13]  E. Spada,et al.  Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) , 2006, Journal of endocrinological investigation.

[14]  E. Sijbrands,et al.  Plasma apolipoprotein A5 and triglycerides in type 2 diabetes , 2006, Diabetologia.

[15]  J. Pitha,et al.  APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohort. , 2006, Clinical biochemistry.

[16]  David W. Williamson,et al.  Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turkss⃞ , 2006, Journal of Lipid Research.

[17]  K. Chien,et al.  A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. , 2003, Human molecular genetics.

[18]  C. Kay,et al.  Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. , 2003, Biochemistry.

[19]  Jonathan C. Cohen,et al.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. , 2002, Human molecular genetics.

[20]  R. Chamuleau,et al.  Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. , 2002, Biochemical and biophysical research communications.

[21]  P. Reitsma,et al.  Apolipoprotein A-V , 2001, The Journal of Biological Chemistry.

[22]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[23]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[24]  K. Lackner,et al.  Apolipoprotein A-V , 2019, Springer Reference Medizin.

[25]  K. V. van Dijk,et al.  Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. , 2007, Atherosclerosis.